Transaction expected to deliver substantial benefits for customers, workers and employees across North America and enhance value for shareholders of both companies Estimated to generate approximately ...
BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results